We studied three FLT3 ITD acute myeloid leukemia (AML) patients who relapsed after allogeneic haematopoietic stem cell transplantation (alloHSCT) and received multikinase inhibitor (MKI) sorafenib as
aResponder to tested mice. bSpecific lysis at 30∶1 effector to target ratio. Percent of specific lysis of targets loaded by P1, P3 and P6 by T cell clones from individual mice at 30∶1 E/T effector to
Treatment resistance of leukemia stem cells (LSCs) and suppression of the autologous immune system represent major challenges to achieve a cure in acute myeloid leukemia (AML). Although AML blasts gen
This Zenodo repository accompanies the study “Functional characterization of specialized immune cells in a cnidarian reveals an ancestral antiviral program”. It provides access to large data files and